PROF - Profound Medical Corp. Trailing Twelve Months Revenue Growth

Brandmark of profoundmedical.com (PROF)

Profound Medical Corp. is implementing the TULSA-PRO system, replacing traditional prostate surgery with non-invasive ablation. Demand for the equipment remains stable, while quarterly seasonality is mitigated by the critical importance of the therapy for oncology centers. The proprietary precision of these methods allows the company to confidently expand its share in urology. The company's TTM annual revenue growth rate demonstrates business resilience, with the latest value recorded as 65.90.

profoundmedical.com (PROF) - Sales Growth YoY (TTM) from 02/11/2024 to 11/15/2026

Profound Medical Corp (PROF) - metric breakdowns and financial figures

- current quotes and average value forecast:
Stock Quotes Profound Medical Corporation|PROF - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Profound Medical Corp.|PROF - Enterprise Value
- book capitalization data:
Equity per Share Profound Medical|PROF - Book Capitalization|Market Capitalization to Book Value profoundmedical.com|PROF - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Profound Medical Corp.|PROF - Long-Term Debt to Capital|Short-Term Debt to Capital Profound Medical Corp.|PROF - Company Debts|Debt to Book Capitalization Ratio Profound Medical Corporation|PROF - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Profound Medical|Immediate Liquidity profoundmedical.com
- earnings and valuation multiples indicators:
PROF - Company Net Income|Projected Net Profit Profound Medical Corp.|PROF - Price to Earnings Ratio|Forward P/E Multiple Profound Medical Corporation|PROF - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Profound Medical Corp|PROF - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Profound Medical|PROF - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months profoundmedical.com|PROF - Earnings growth in current year|Expected net earnings per share growth next year Profound Medical Corp.
- sales revenue and business income indicators:
PROF - Company Revenue|Company Revenue Forecast profoundmedical.com|PROF - Market Cap to Revenue|Price to Expected Revenue Ratio Profound Medical Corp|PROF - Sales Growth YoY (Last Twelve Months)
Analysis of all company metrics:Profound Medical Corp (PROF)
Mass-produced product of Profound Medical

Assessing the financial stability of Profound Medical Corp. (PROF) requires an analysis of the actual demand for the TULSA-PRO system for non-invasive prostate cancer treatment. The LTM sales growth rate mathematically strips revenue of seasonality and market noise, allowing investors to distinguish the fundamental expansion of the partner clinic network from random price fluctuations and avoid purchasing an overvalued asset.

Competitor analysis for Profound Medical Corp.

DXCM - Revenue Growth YoY (Last 12 Months)|Penumbra - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Novanta Inc.|HAE: Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) INSP|PRCT (Procept) - Sales Growth YoY (TTM)|CONMED Corp. (CNMD) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PLSE|Revenue Growth YoY (Last 12 Months) InMode Ltd. INMD|Sales Growth YoY (Last Twelve Months) Picard Medical PMI|Sales Growth YoY (TTM) Surmodics Inc SRDX|SENS - Sales Growth YoY (Last Twelve Months)|NPCE: Sales Growth YoY (Last Twelve Months)|TCMD (Tactile Systems Technology Inc.) - Revenue Growth YoY (Last 12 Months)|Sanuwave Health Inc - Revenue Dynamics YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OM|Trailing Twelve Months Revenue Growth smartvest.com ELMD|Sales Growth YoY (Last Twelve Months) LENSAR Inc. (LNSR)|AVITA Medical, Inc. (RCEL) - Revenue Growth Rate YoY (Last Twelve Months)|Baird Medical Investment Holdings - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) EDAP Medical EDAP|Apyx Medical Corp - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) IceCure Medical ICCM|Pulmonx (LUNG) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth TELA (TELA Bio Corp)|Sales Growth YoY (Last Twelve Months) cytosorbents.com|Revenue Growth YoY (Last 12 Months) Sensus Healthcare, Inc. (SRTS)|Sales Growth YoY (TTM) ZYXI|ECOR - Trailing Twelve Months Revenue Growth|Sales Growth YoY (Last Twelve Months) vicarioussurgical.com RBOT|IINN: Sales Growth YoY (Last 12 Months)|ICU - Sales Growth YoY (Last Twelve Months)|iridex.com - Revenue Change YoY (Last 12 Months)|INBS: Sales Growth YoY (TTM)|XAIR (Beyond Air Inc) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Profusa, Inc.|SSKN (strataskinsciences.com) - Revenue Change YoY (Last 12 Months)|Revenue Growth YoY (Last 12 Months) GCTK (GlucoTrack Inc.)|nanovibronix.com - Sales Growth YoY (Last 12 Months)|venusconcept.com - Revenue Growth YoY (Last 12 Months)|Nuwellis Inc (NUWE) - Trailing Twelve Months Revenue Growth|AEMD - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Asensus Surgical Inc ASXC|AVGR: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) BioSig Technologies, Inc. BSGM|Revenue Growth YoY (Last 12 Months) CUTR|Sales Growth YoY (Last Twelve Months) KNW|Sales Growth YoY (TTM) NARI|NVRO - Trailing Twelve Months Revenue Growth|Sales Growth YoY (Last Twelve Months) ReShape Lifesciences Inc RSLS|SILK: Sales Growth YoY (Last 12 Months)